Medtronic has landed on a new brand for the planned spinout of its diabetes division, and it didn’t have to look very far. The new company will share a name with its flagship insulin pump, MiniMed.

Medtronic has secured a new approval in Europe, greatly expanding the reach of its MiniMed 780G pump system—including for people with Type 2 diabetes who require insulin. The CE mark also opens it up ...

GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the ...

Medtronic (NYSE:MDT) announced on Tuesday that the U.S. FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing the integration of its MiniMed 780G insulin ...

Medtronic plc MDT recently achieved the CE Mark for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) that does not require any fingersticks or over ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with the MiniMed 780G system. The all-in-one sensor is said to eliminate the ...